Expensive colonoscopies that cost a patient over $1,000 on average could soon be replaced by simpler and much cheaper tests as non-invasive screening options become more available and more ...

We compared the clinical and nonclinical costs across program years among CRCCP grantees offering colonoscopy, FOBT/FIT, or both tests for CRC screening. Our findings expand on our prior analysis and ...

Contextual socio-economic factors, health-care access, and general practitioner (GP) involvement may influence colonoscopy uptake and its timing after positive faecal occult blood testing (FOBT). Our ...

Physicians should screen for colorectal cancer in asymptomatic, low-risk adults aged 50 to 74 years every two years using fecal occult blood testing (FOBT), or flexible sigmoidoscopy every 10 years, ...

Bowel cancer is a serious health burden and its early diagnosis improves survival. The Bowel Cancer Screening Programme (BCSP) in England screens with the Faecal Occult Blood test (FOBt), followed by ...

A survey of adults eligible for colorectal cancer screening patterns found a preference for at-home fecal occult blood testing (FOBT) versus colonoscopy during the COVID-19 pandemic. Survey ...

Abnormal results of guaiac fecal occult blood testing (FOBT) may flag a higher mortality risk that extends beyond death from colorectal cancer, a Scottish study showed. The study, which had as much as ...

Though it claimed the lives of more than 50,000 Americans in 2010 alone, colon cancer is actually a largely preventable disease when people adhere to the recommended screening guidelines. According to ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...

Patients whose colorectal cancer is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test. Patients whose colorectal ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Headlines are meant to grab your attention. So, if you read ...